US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRI BIO INC

0.4193

-0.0593-12.39%

Post-market: 0.4106-0.0087-2.07%19:43 EST

Volume:1.20M

Turnover:521.06K

Market Cap:2.46M

PE:-0.03

High:0.4720

Open:0.4695

Low:0.3950

Close:0.4786

52wk High:15.64

52wk Low:0.3950

Shares:5.87M

Float Shares:5.87M

Volume Ratio:0.29

T/O Rate:20.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-13.9488

EPS(LYR):-55.2058

ROE:-397.84%

ROA:-137.52%

PB:1.24

PE(LYR):-0.01

Loading ...

Overview Company News Filings

GRI Bio Inc expected to post a loss of $1.31 a share - Earnings Preview

Mueller Water Products Releases 2024 ESG Report

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment

Crude Oil Falls 1%; Meta Earnings Top Views

Two Senior Executives from S&P and the Global Reporting Initiative (GRI) join the Diginex team

GRI Bio Inc. Announces Encouraging Interim Results from Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis

GRI Bio Inc - Topline Results From Phase 2a Biomarker Study Expected Q3 2025

THOMSON REUTERS

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“Ipf”)

THOMSON REUTERS

GRI Bio Inc - Phase 2a Study Fully Enrolled; Topline Data Expected Q3 2025

THOMSON REUTERS

GRI Bio Inc - Idmc Recommends Continuation of Study With No Safety Concerns

THOMSON REUTERS

BRIEF-GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Inc. Announces Positive Interim Safety Results from Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GRI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":0.4193,"timestamp":1766005200000,"preClose":0.4786,"halted":0,"volume":1202981,"hourTrading":{"tag":"盘后","latestPrice":0.4106,"preClose":0.4193,"latestTime":"19:43 EST","volume":147344,"amount":60055.1828,"timestamp":1766018591006},"delay":0,"floatShares":5871600,"shares":5872058,"eps":-13.948769,"marketStatus":"Not Yet Opened","change":-0.0593,"latestTime":"12-17 16:00:00 EST","open":0.4695,"high":0.471999,"low":0.395,"amount":521056.83249724,"amplitude":0.160884,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-13.948769,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":0,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.4786,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":0.4685,"preClose":0.4786,"latestTime":"09:25 EST","volume":9456,"amount":4423.99272048,"timestamp":1765981513281},"postHourTrading":{"tag":"盘后","latestPrice":0.4106,"preClose":0.4193,"latestTime":"19:43 EST","volume":147344,"amount":60055.1828,"timestamp":1766018591006},"volumeRatio":0.29362},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","floatShares":5871600,"roa":"-137.52%","roe":"-397.84%","lyrEps":-55.205753,"volumeRatio":0.29362,"shares":5872058,"dividePrice":0,"high":0.471999,"amplitude":0.160884,"preClose":0.4786,"low":0.395,"week52Low":0.395,"pbRate":"1.24","week52High":15.64,"institutionHeld":0,"latestPrice":0.4193,"eps":-13.948769,"divideRate":0,"volume":1202981,"delay":0,"ttmEps":-13.948769,"open":0.4695,"prevYearClose":14.0828,"prevWeekClose":0.528,"prevMonthClose":2,"prevQuarterClose":2.06,"fiveDayClose":1.21,"twentyDayClose":1.79,"sixtyDayClose":1.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"GRI","fiscalQuarterEnding":"2025/09","expectedEps":-1.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-1.28},{"market":"US","date":"2025-08-14","symbol":"GRI","fiscalQuarterEnding":"2025/06","expectedEps":-1.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2025-05-15","symbol":"GRI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-5.8},{"market":"US","date":"2025-03-17","symbol":"GRI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-02-24","symbol":"GRI","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":17,"toFactor":1,"ratio":17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRI\",market:\"US\",,,undefined,":[{"executeDate":"2017-06-21","recordDate":null,"paymentDate":null,"value":0.35098,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":null,"paymentDate":null,"value":0.3314,"currency":"USD"},{"executeDate":"2018-03-22","recordDate":null,"paymentDate":null,"value":0.21998,"currency":"USD"},{"executeDate":"2018-06-21","recordDate":null,"paymentDate":null,"value":0.43792,"currency":"USD"},{"executeDate":"2018-09-20","recordDate":null,"paymentDate":null,"value":0.22115,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1733806800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRI","date":"2025-12-16","current":-0.03006,"percent":0.675799,"low":-67.389471,"twenty":-0.681024,"median":-0.335859,"eighty":-0.102335,"high":-0.026053,"avg":-0.864869,"sd":2.95685,"marketCap":1552645},"quantilePoints":[{"date":"2023-04-28","current":-6.452842,"twenty":-43.014819,"median":-6.452842,"eighty":-5.86271,"marketCap":20758792},{"date":"2023-05-05","current":-6.462034,"twenty":-6.958407,"median":-6.590723,"eighty":-6.414235,"marketCap":20788363},{"date":"2023-05-12","current":-6.241424,"twenty":-6.746989,"median":-6.452842,"eighty":-6.208332,"marketCap":20078661},{"date":"2023-05-19","current":-5.533634,"twenty":-6.616461,"median":-6.31496,"eighty":-5.658793,"marketCap":17801699},{"date":"2023-05-26","current":-5.561302,"twenty":-6.458357,"median":-6.186271,"eighty":-5.598088,"marketCap":17890708},{"date":"2023-06-02","current":-5.262646,"twenty":-6.452842,"median":-5.82778,"eighty":-5.482158,"marketCap":16929933},{"date":"2023-06-09","current":-5.525778,"twenty":-6.449165,"median":-5.749648,"eighty":-5.42597,"marketCap":17776429},{"date":"2023-06-16","current":-5.552999,"twenty":-6.425266,"median":-5.726667,"eighty":-5.42597,"marketCap":17863998},{"date":"2023-06-23","current":-5.27172,"twenty":-6.388497,"median":-5.639618,"eighty":-5.389675,"marketCap":16959122},{"date":"2023-06-30","current":-3.937911,"twenty":-6.292899,"median":-5.570402,"eighty":-5.286238,"marketCap":12668260},{"date":"2023-07-07","current":-3.937911,"twenty":-6.252454,"median":-5.552999,"eighty":-5.259017,"marketCap":12668260},{"date":"2023-07-14","current":-2.385349,"twenty":-6.208332,"median":-5.497533,"eighty":-4.422437,"marketCap":12084177},{"date":"2023-07-21","current":-2.080028,"twenty":-6.169725,"median":-5.444117,"eighty":-3.992352,"marketCap":10537423},{"date":"2023-07-28","current":-2.074266,"twenty":-6.062039,"median":-5.398749,"eighty":-2.492577,"marketCap":10508234},{"date":"2023-08-04","current":-2.016648,"twenty":-5.895709,"median":-5.29894,"eighty":-2.286879,"marketCap":10216339},{"date":"2023-08-11","current":-1.670937,"twenty":-5.80594,"median":-5.269392,"eighty":-2.115752,"marketCap":8464966},{"date":"2023-08-18","current":-0.705381,"twenty":-5.784454,"median":-5.253573,"eighty":-2.071731,"marketCap":8123173},{"date":"2023-08-25","current":-0.379941,"twenty":-5.775512,"median":-4.672867,"eighty":-2.016648,"marketCap":4375403},{"date":"2023-09-01","current":-0.326031,"twenty":-5.745051,"median":-4.137529,"eighty":-1.921001,"marketCap":3754569},{"date":"2023-09-08","current":-0.3029,"twenty":-5.7189,"median":-4.028646,"eighty":-1.605021,"marketCap":3488202},{"date":"2023-09-15","current":-0.344001,"twenty":-5.680197,"median":-3.282658,"eighty":-0.71008,"marketCap":3961514},{"date":"2023-09-22","current":-0.388926,"twenty":-5.612229,"median":-2.48912,"eighty":-0.572479,"marketCap":4478876},{"date":"2023-09-29","current":-0.427434,"twenty":-5.570848,"median":-2.355128,"eighty":-0.40895,"marketCap":4922329},{"date":"2023-10-06","current":-0.431285,"twenty":-5.566762,"median":-2.183742,"eighty":-0.40818,"marketCap":4966674},{"date":"2023-10-13","current":-0.385076,"twenty":-5.557981,"median":-2.111719,"eighty":-0.394317,"marketCap":4434531},{"date":"2023-10-20","current":-0.30806,"twenty":-5.545253,"median":-2.080028,"eighty":-0.388156,"marketCap":3547624},{"date":"2023-10-27","current":-0.29009,"twenty":-5.537507,"median":-2.074266,"eighty":-0.385076,"marketCap":3340680},{"date":"2023-11-03","current":-0.313195,"twenty":-5.527349,"median":-2.035374,"eighty":-0.378144,"marketCap":3606751},{"date":"2023-11-10","current":-0.326031,"twenty":-5.480587,"median":-2.016648,"eighty":-0.338353,"marketCap":3754569},{"date":"2023-11-17","current":-0.236451,"twenty":-5.463669,"median":-1.982077,"eighty":-0.328085,"marketCap":3145265},{"date":"2023-11-24","current":-0.183038,"twenty":-5.451376,"median":-1.754484,"eighty":-0.323726,"marketCap":2434765},{"date":"2023-12-01","current":-0.149115,"twenty":-5.430507,"median":-1.596033,"eighty":-0.313195,"marketCap":1983522},{"date":"2023-12-08","current":-0.135594,"twenty":-5.413267,"median":-1.130208,"eighty":-0.310628,"marketCap":1803674},{"date":"2023-12-15","current":-0.104697,"twenty":-5.396934,"median":-0.705381,"eighty":-0.306725,"marketCap":1392685},{"date":"2023-12-22","current":-0.090567,"twenty":-5.373343,"median":-0.587882,"eighty":-0.302916,"marketCap":1204721},{"date":"2023-12-29","current":-0.094904,"twenty":-5.349752,"median":-0.438986,"eighty":-0.2983,"marketCap":1262416},{"date":"2024-01-05","current":-0.110474,"twenty":-5.311643,"median":-0.435136,"eighty":-0.294711,"marketCap":1469527},{"date":"2024-01-12","current":-0.109217,"twenty":-5.291682,"median":-0.427434,"eighty":-0.246147,"marketCap":1452802},{"date":"2024-01-19","current":-0.097153,"twenty":-5.278979,"median":-0.423583,"eighty":-0.216462,"marketCap":1292334},{"date":"2024-01-26","current":-0.094979,"twenty":-5.268926,"median":-0.399195,"eighty":-0.171402,"marketCap":1263405},{"date":"2024-02-02","current":-0.094661,"twenty":-5.264413,"median":-0.392777,"eighty":-0.137831,"marketCap":1259185},{"date":"2024-02-09","current":-0.06068,"twenty":-5.257202,"median":-0.388926,"eighty":-0.126623,"marketCap":807170},{"date":"2024-02-16","current":-0.051457,"twenty":-5.14469,"median":-0.385076,"eighty":-0.111663,"marketCap":684480},{"date":"2024-02-23","current":-0.04102,"twenty":-4.999514,"median":-0.382508,"eighty":-0.110454,"marketCap":545646},{"date":"2024-03-01","current":-0.03886,"twenty":-4.71642,"median":-0.375448,"eighty":-0.10718,"marketCap":516911},{"date":"2024-03-08","current":-0.039161,"twenty":-4.422437,"median":-0.344001,"eighty":-0.100549,"marketCap":520915},{"date":"2024-03-15","current":-0.03767,"twenty":-4.279076,"median":-0.334836,"eighty":-0.098655,"marketCap":501091},{"date":"2024-03-22","current":-0.038156,"twenty":-4.093976,"median":-0.328598,"eighty":-0.095596,"marketCap":507548},{"date":"2024-03-28","current":-0.03767,"twenty":-4.028646,"median":-0.326031,"eighty":-0.094235,"marketCap":501091},{"date":"2024-04-05","current":-0.0264,"twenty":-4.010499,"median":-0.323464,"eighty":-0.087028,"marketCap":344177},{"date":"2024-04-12","current":-0.125045,"twenty":-3.937911,"median":-0.313195,"eighty":-0.088985,"marketCap":1630208},{"date":"2024-04-19","current":-0.126859,"twenty":-3.67581,"median":-0.313195,"eighty":-0.09094,"marketCap":1653862},{"date":"2024-04-26","current":-0.105479,"twenty":-2.6009,"median":-0.310628,"eighty":-0.09277,"marketCap":1375129},{"date":"2024-05-03","current":-0.105185,"twenty":-2.49373,"median":-0.30806,"eighty":-0.094235,"marketCap":1371293},{"date":"2024-05-10","current":-0.10033,"twenty":-2.46953,"median":-0.302926,"eighty":-0.09471,"marketCap":1308002},{"date":"2024-05-17","current":-0.103221,"twenty":-2.390004,"median":-0.302913,"eighty":-0.094919,"marketCap":1318551},{"date":"2024-05-24","current":-0.122034,"twenty":-2.373261,"median":-0.297792,"eighty":-0.095113,"marketCap":1558863},{"date":"2024-05-31","current":-0.089235,"twenty":-2.324907,"median":-0.295225,"eighty":-0.094904,"marketCap":1139886},{"date":"2024-06-07","current":-0.082262,"twenty":-2.229836,"median":-0.270731,"eighty":-0.09243,"marketCap":1050809},{"date":"2024-06-14","current":-0.067369,"twenty":-2.183742,"median":-0.243952,"eighty":-0.086638,"marketCap":860576},{"date":"2024-06-21","current":-0.06046,"twenty":-2.183742,"median":-0.236451,"eighty":-0.084684,"marketCap":772312},{"date":"2024-06-28","current":-0.04364,"twenty":-2.142256,"median":-0.183038,"eighty":-0.080138,"marketCap":557458},{"date":"2024-07-05","current":-0.035685,"twenty":-2.107685,"median":-0.169273,"eighty":-0.077002,"marketCap":455838},{"date":"2024-07-12","current":-0.039549,"twenty":-2.084638,"median":-0.148382,"eighty":-0.067451,"marketCap":505197},{"date":"2024-07-19","current":-0.133962,"twenty":-2.080028,"median":-0.136425,"eighty":-0.065043,"marketCap":1711236},{"date":"2024-07-26","current":-0.250214,"twenty":-2.076571,"median":-0.134227,"eighty":-0.066114,"marketCap":3196229},{"date":"2024-08-02","current":-0.123557,"twenty":-2.070463,"median":-0.136308,"eighty":-0.067151,"marketCap":1578317},{"date":"2024-08-09","current":-0.119179,"twenty":-2.057903,"median":-0.134149,"eighty":-0.067451,"marketCap":1522398},{"date":"2024-08-16","current":-0.173723,"twenty":-2.032205,"median":-0.134188,"eighty":-0.068945,"marketCap":1438081},{"date":"2024-08-23","current":-0.180019,"twenty":-2.0178,"median":-0.137022,"eighty":-0.072461,"marketCap":1490194},{"date":"2024-08-30","current":-0.179523,"twenty":-2.016648,"median":-0.143852,"eighty":-0.075548,"marketCap":1486095},{"date":"2024-09-06","current":-0.181256,"twenty":-2.012038,"median":-0.150555,"eighty":-0.076825,"marketCap":1500441},{"date":"2024-09-13","current":-0.17772,"twenty":-1.99821,"median":-0.158633,"eighty":-0.077735,"marketCap":1471164},{"date":"2024-09-20","current":-0.155898,"twenty":-1.983229,"median":-0.162446,"eighty":-0.078438,"marketCap":1290525},{"date":"2024-09-27","current":-0.157737,"twenty":-1.921001,"median":-0.162689,"eighty":-0.07939,"marketCap":1305749},{"date":"2024-10-04","current":-0.126614,"twenty":-1.771193,"median":-0.158185,"eighty":-0.081212,"marketCap":1048113},{"date":"2024-10-11","current":-0.142706,"twenty":-1.649964,"median":-0.155898,"eighty":-0.082328,"marketCap":1181323},{"date":"2024-10-18","current":-0.205129,"twenty":-1.609516,"median":-0.156191,"eighty":-0.082669,"marketCap":1698060},{"date":"2024-10-25","current":-0.253618,"twenty":-1.58474,"median":-0.158633,"eighty":-0.083857,"marketCap":2099446},{"date":"2024-11-01","current":-0.389038,"twenty":-1.55835,"median":-0.162689,"eighty":-0.085216,"marketCap":3220459},{"date":"2024-11-08","current":-0.309533,"twenty":-1.213002,"median":-0.16573,"eighty":-0.0855,"marketCap":2562314},{"date":"2024-11-15","current":-0.834738,"twenty":-0.956624,"median":-0.168878,"eighty":-0.086051,"marketCap":6897440},{"date":"2024-11-22","current":-0.744896,"twenty":-0.798801,"median":-0.172945,"eighty":-0.087419,"marketCap":6155078},{"date":"2024-11-29","current":-0.73895,"twenty":-0.817115,"median":-0.173652,"eighty":-0.088719,"marketCap":6105945},{"date":"2024-12-06","current":-0.85409,"twenty":-0.817115,"median":-0.175474,"eighty":-0.089501,"marketCap":7057347},{"date":"2024-12-13","current":-0.864901,"twenty":-0.90556,"median":-0.177225,"eighty":-0.09094,"marketCap":7146680},{"date":"2024-12-20","current":-0.800034,"twenty":-0.862739,"median":-0.178604,"eighty":-0.092559,"marketCap":6610679},{"date":"2024-12-27","current":-0.840252,"twenty":-0.85409,"median":-0.179258,"eighty":-0.093076,"marketCap":6943000},{"date":"2025-01-03","current":-0.980582,"twenty":-0.899629,"median":-0.179576,"eighty":-0.093918,"marketCap":8102549},{"date":"2025-01-10","current":-0.824359,"twenty":-0.897162,"median":-0.179967,"eighty":-0.094448,"marketCap":6811680},{"date":"2025-01-17","current":-0.778736,"twenty":-0.894437,"median":-0.183038,"eighty":-0.094807,"marketCap":6434692},{"date":"2025-01-24","current":-0.664677,"twenty":-0.882156,"median":-0.183767,"eighty":-0.094934,"marketCap":5492224},{"date":"2025-01-31","current":-0.683272,"twenty":-0.864036,"median":-0.186432,"eighty":-0.095246,"marketCap":5645877},{"date":"2025-02-07","current":-0.51786,"twenty":-0.859279,"median":-0.188825,"eighty":-0.095801,"marketCap":4279075},{"date":"2025-02-14","current":-0.59462,"twenty":-0.851712,"median":-0.211495,"eighty":-0.096227,"marketCap":4913342},{"date":"2025-02-21","current":-0.448668,"twenty":-0.847171,"median":-0.237801,"eighty":-0.096648,"marketCap":3707340},{"date":"2025-02-28","current":-0.503678,"twenty":-0.842674,"median":-0.243952,"eighty":-0.097277,"marketCap":4161888},{"date":"2025-03-07","current":-0.417118,"twenty":-0.839149,"median":-0.250793,"eighty":-0.097785,"marketCap":3446642},{"date":"2025-03-14","current":-0.38344,"twenty":-0.834284,"median":-0.285059,"eighty":-0.097973,"marketCap":3146894},{"date":"2025-03-21","current":-0.529391,"twenty":-0.832468,"median":-0.291725,"eighty":-0.098547,"marketCap":4344710},{"date":"2025-03-28","current":-0.279508,"twenty":-0.831517,"median":-0.292657,"eighty":-0.098601,"marketCap":2293923},{"date":"2025-04-04","current":-0.09666,"twenty":-0.827041,"median":-0.290527,"eighty":-0.098547,"marketCap":793290},{"date":"2025-04-11","current":-0.085138,"twenty":-0.823818,"median":-0.279508,"eighty":-0.096759,"marketCap":698726},{"date":"2025-04-17","current":-0.09666,"twenty":-0.821656,"median":-0.251372,"eighty":-0.09666,"marketCap":793290},{"date":"2025-04-25","current":-0.116504,"twenty":-0.814953,"median":-0.245324,"eighty":-0.09666,"marketCap":956151},{"date":"2025-05-02","current":-0.134428,"twenty":-0.809764,"median":-0.239152,"eighty":-0.09666,"marketCap":1103251},{"date":"2025-05-09","current":-0.0941,"twenty":-0.808683,"median":-0.211495,"eighty":-0.09666,"marketCap":772276},{"date":"2025-05-16","current":-0.084138,"twenty":-0.800034,"median":-0.204843,"eighty":-0.096031,"marketCap":788037},{"date":"2025-05-23","current":-0.070115,"twenty":-0.798953,"median":-0.187157,"eighty":-0.094904,"marketCap":656697},{"date":"2025-05-30","current":-0.343344,"twenty":-0.795147,"median":-0.196834,"eighty":-0.094964,"marketCap":3215762},{"date":"2025-06-06","current":-0.358381,"twenty":-0.793245,"median":-0.205801,"eighty":-0.0953,"marketCap":3356598},{"date":"2025-06-13","current":-0.350863,"twenty":-0.792574,"median":-0.237801,"eighty":-0.095594,"marketCap":3286180},{"date":"2025-06-20","current":-0.350863,"twenty":-0.79052,"median":-0.242668,"eighty":-0.095877,"marketCap":3286180},{"date":"2025-06-27","current":-0.320789,"twenty":-0.782931,"median":-0.250214,"eighty":-0.096326,"marketCap":3004508},{"date":"2025-07-03","current":-0.360887,"twenty":-0.772292,"median":-0.253618,"eighty":-0.096577,"marketCap":3380071},{"date":"2025-07-11","current":-0.395974,"twenty":-0.758129,"median":-0.287575,"eighty":-0.09666,"marketCap":3708689},{"date":"2025-07-18","current":-0.519833,"twenty":-0.748788,"median":-0.292486,"eighty":-0.09666,"marketCap":4868760},{"date":"2025-07-25","current":-0.525165,"twenty":-0.744896,"median":-0.295553,"eighty":-0.096857,"marketCap":4918696},{"date":"2025-08-01","current":-0.341224,"twenty":-0.744464,"median":-0.297792,"eighty":-0.097401,"marketCap":3195904},{"date":"2025-08-08","current":-0.333227,"twenty":-0.742821,"median":-0.300679,"eighty":-0.097796,"marketCap":3121000},{"date":"2025-08-15","current":-0.359252,"twenty":-0.741156,"median":-0.302926,"eighty":-0.097873,"marketCap":3595392},{"date":"2025-08-22","current":-0.349348,"twenty":-0.740118,"median":-0.303824,"eighty":-0.098183,"marketCap":3496273},{"date":"2025-08-29","current":-0.349348,"twenty":-0.737004,"median":-0.30806,"eighty":-0.098547,"marketCap":3496273},{"date":"2025-09-05","current":-0.376994,"twenty":-0.732571,"median":-0.309674,"eighty":-0.098601,"marketCap":3772957},{"date":"2025-09-12","current":-0.515225,"twenty":-0.725652,"median":-0.310597,"eighty":-0.09883,"marketCap":5156375},{"date":"2025-09-19","current":-0.485066,"twenty":-0.721003,"median":-0.310628,"eighty":-0.098953,"marketCap":4854538},{"date":"2025-09-26","current":-0.485066,"twenty":-0.714988,"median":-0.313195,"eighty":-0.099431,"marketCap":4854538},{"date":"2025-10-03","current":-0.495119,"twenty":-0.709175,"median":-0.313195,"eighty":-0.100278,"marketCap":4955150},{"date":"2025-10-10","current":-0.495119,"twenty":-0.70593,"median":-0.319536,"eighty":-0.100317,"marketCap":4955150},{"date":"2025-10-17","current":-0.490092,"twenty":-0.705684,"median":-0.323295,"eighty":-0.100364,"marketCap":4904844},{"date":"2025-10-24","current":-0.510199,"twenty":-0.704635,"median":-0.323682,"eighty":-0.100506,"marketCap":5106069},{"date":"2025-10-31","current":-0.402127,"twenty":-0.699489,"median":-0.325801,"eighty":-0.100531,"marketCap":4024488},{"date":"2025-11-07","current":-0.44234,"twenty":-0.690624,"median":-0.327169,"eighty":-0.100549,"marketCap":4426936},{"date":"2025-11-14","current":-0.424747,"twenty":-0.689408,"median":-0.328598,"eighty":-0.100733,"marketCap":4250865},{"date":"2025-11-21","current":-0.592993,"twenty":-0.687056,"median":-0.330989,"eighty":-0.101551,"marketCap":6668203},{"date":"2025-11-28","current":-0.581365,"twenty":-0.683272,"median":-0.333227,"eighty":-0.101876,"marketCap":6537454},{"date":"2025-12-05","current":-0.622061,"twenty":-0.68111,"median":-0.335826,"eighty":-0.102095,"marketCap":6995075},{"date":"2025-12-12","current":-0.153161,"twenty":-0.68111,"median":-0.33594,"eighty":-0.102277,"marketCap":1722292},{"date":"2025-12-16","current":-0.138074,"twenty":-0.681024,"median":-0.335859,"eighty":-0.102335,"marketCap":1552645}],"updateTime":1766011835814},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRI\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557575484","title":"GRI Bio Inc  expected to post a loss of $1.31 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557575484","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557575484?lang=en_us&edition=fundamental","pubTime":"2025-08-08 23:53","pubTimestamp":1754668383,"startTime":"0","endTime":"0","summary":"GRI Bio Inc  expected to post a loss of $1.31 a share - Earnings Preview GRI Bio Inc GRI.OQ GRI.O is expected to  report resultson August 12 (estimated) for the period ending June 30 2025LSEG's mean a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2556387299","title":"Mueller Water Products Releases 2024 ESG Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387299","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556387299?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:04","pubTimestamp":1754312640,"startTime":"0","endTime":"0","summary":"Report Highlights Several Key AchievementsATLANTA, Aug.  04, 2025  (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA), a leading manufacturer and marketer of products and solutions used in t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/04/3126637/14520/en/Mueller-Water-Products-Releases-2024-ESG-Report.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","LU1165135440.EUR","MLI","BK4007","BK4585","ESG","MWA","BK4142","LU2229751404.USD","GHG","LU1543694498.USD","BK4139","LU2308191902.HKD","LU1721427968.SGD","LU2089279066.USD","GRI"],"gpt_icon":0},{"id":"2556830664","title":"GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2556830664","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556830664?lang=en_us&edition=fundamental","pubTime":"2025-08-01 01:50","pubTimestamp":1753984200,"startTime":"0","endTime":"0","summary":"Access the “What This Means” segment here LA JOLLA, CA, July  31, 2025  (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/31/3125304/0/en/GRI-Bio-CEO-Marc-Hertz-Participates-in-Virtual-Investor-What-This-Means-Segment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2556837086","title":"Crude Oil Falls 1%; Meta Earnings Top Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2556837086","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556837086?lang=en_us&edition=fundamental","pubTime":"2025-08-01 01:25","pubTimestamp":1753982708,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"8528e680f18ff6a358396ae8f1d89afd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/07/46767954/crude-oil-falls-1-meta-earnings-top-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","LUNG","META","FB","SNGX","ALGN","VRME"],"gpt_icon":1},{"id":"2555635834","title":"Two Senior Executives from S&P and the Global Reporting Initiative (GRI) join the Diginex team","url":"https://stock-news.laohu8.com/highlight/detail?id=2555635834","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555635834?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:16","pubTimestamp":1753967760,"startTime":"0","endTime":"0","summary":"LONDON, July  31, 2025  (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, is delighted to announce the appointmen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/31/3125088/0/en/Two-Senior-Executives-from-S-P-and-the-Global-Reporting-Initiative-GRI-join-the-Diginex-team.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4139","BK4023","BK4007","DGNX"],"gpt_icon":0},{"id":"2555835672","title":"GRI Bio Inc. Announces Encouraging Interim Results from Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2555835672","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555835672?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:03","pubTimestamp":1753967004,"startTime":"0","endTime":"0","summary":"GRI Bio Inc. has announced the release of 6-week interim biomarker data from its ongoing Phase 2a study of GRI-0621 in treating Idiopathic Pulmonary Fibrosis . The interim results indicate positive impacts on fibrogenesis, fibrolysis, and potentially the initiation of a repair response. The study, fully enrolled with 12 participants, aims to assess the safety and tolerability of oral GRI-0621, as well as its pharmacokinetics and pharmacodynamic activity. The Independent Data Monitoring Committee has recommended continuing the study as planned, citing no safety concerns. Topline data is anticipated in the third quarter of 2025, with potential findings on pulmonary function expected in the coming weeks. Currently, treatments for IPF are limited, with existing options having significant side-effects and no impact on survival.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL1h1lH2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2555835374","title":"GRI Bio Inc - Topline Results From Phase 2a Biomarker Study Expected Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555835374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555835374?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:00","pubTimestamp":1753966801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUA81HWYY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2555558835","title":"GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“Ipf”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2555558835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555558835?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:00","pubTimestamp":1753966801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUA81HWYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2555545835","title":"GRI Bio Inc - Phase 2a Study Fully Enrolled; Topline Data Expected Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555545835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555545835?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:00","pubTimestamp":1753966801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUA81HWYY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2555355488","title":"GRI Bio Inc - Idmc Recommends Continuation of Study With No Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2555355488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555355488?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:00","pubTimestamp":1753966801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUA81HWYY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2548001924","title":"BRIEF-GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548001924","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548001924?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:54","pubTimestamp":1751374475,"startTime":"0","endTime":"0","summary":"BRIEF-GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)July 1 (Reuters) - GRI Bio Inc GRI.O:GRI BIO COMPLETES ENROLLMENT IN PHASE 2A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA3TKQYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2546560780","title":"GRI Bio Inc. Announces Positive Interim Safety Results from Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2546560780","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546560780?lang=en_us&edition=fundamental","pubTime":"2025-06-26 20:01","pubTimestamp":1750939308,"startTime":"0","endTime":"0","summary":"GRI Bio Inc. has announced positive interim safety results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis . The Independent Data Monitoring Committee has recommended the continuation of the study as no safety concerns were identified in the interim analysis of the first 24 patients. GRI-0621, a small molecule RAR-β dual agonist, is being investigated for its potential to inhibit Type 1 Invariant NKT cells, which may play a role in fibrotic diseases. Interim biomarker data from the study are expected in July 2025, with topline results anticipated in the third quarter of 2025. Currently, only two approved drugs for IPF exist, both with significant side effects and limited impact on patient survival.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL8Sq8HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":52,"code":"91000000","status":"200"}]}}